HDX-MS takes centre stage at unravelling kinase dynamics

K Lorenzen, T Pawson - Biochemical Society Transactions, 2014 - portlandpress.com
In recent years, HDX-MS (hydrogen–deuterium exchange coupled to MS) on biomolecules
has evolved from a niche technique to a powerful method in the investigation of protein …

Molecular targeted therapy, advanced treatment for cancers of the head-and-neck region: A systematic review

F Shaikh, SK Sodhi, LM Kale, ZF Farooqui… - Journal of Cancer …, 2023 - journals.lww.com
Aim: The aim of the study is to carry out a systematic review of clinical trials of molecular
targeted therapy in the treatment of cancer. Objective: The objective of the study is to …

Vascular endothelial growth factor–targeted paclitaxel‐loaded liposome microbubbles and inhibition of human epidermoid‐2 cell proliferation

L Zhou, W Luo - Head & Neck, 2017 - Wiley Online Library
Background Vascular endothelial growth factor (VEGF) plays an important role in the
formation of capillary blood vessels. The purpose of this study was to evaluate the inhibitory …

Interdisciplinary Approach in Head and Neck Cancers

M Sabahi, S Hanaei, N Rezaei - 2022 - Springer
Head and neck cancers, as well as the therapies used to treat them, may result in
considerable and long-term disabilities that decrease the patients' quality of life. Thus …

Dysregulation of ß‐catenin, WISP1 and TCF21 predicts disease‐specific survival and primary response against radio (chemo) therapy in patients with locally …

E Vyskocil, J Pammer, G Altorjai, MC Grasl… - Clinical …, 2019 - Wiley Online Library
Objective The objective of this study was to determine the prognostic and predictive impact
of β‐catenin, TCF21 and WISP1 expression in patients with squamous cell carcinomas of …

Current role of dacomitinib in head and neck cancer

O Elicin, M Ozsahin - Expert opinion on investigational drugs, 2016 - Taylor & Francis
Introduction: Recurrent and/or metastatic head and neck squamous cell carcinoma
(HNSCC) has a dismal prognosis. With the emergence of monoclonal antibodies and …

Frontal sinus carcinoma in forty‐one dogs (2001–2022)

J Gedon, M Kessler, JM Schmidt - Veterinary and Comparative …, 2023 - Wiley Online Library
Reports on canine frontal sinus carcinomas (FSCs) are scarce. This retrospective review of
41 dogs with FSC (2001–2022) describes demographic and clinical characteristics of canine …

[图书][B] Radiotherapy and clinical radiobiology of head and neck cancer

LG Marcu, I Toma-Dasu, A Dasu, C Mercke - 2018 - taylorfrancis.com
Common factors that lead to treatment failure in head and neck cancer are the lack of tumour
oxygenation, the accelerated division of cancer cells during treatment, and radioresistance …

The Effect of Canertinib on Sensitivity of Cytotoxic Drugs in Tamoxifen‐Resistant Breast Cancer Cells In Vitro

HAM Gomaa, AT Ali, MA Gabbar… - International Journal of …, 2018 - Wiley Online Library
Aims and Objectives. To investigate and examine the reversal effects of canertinib on the
activity of EGFR and tamoxifen resistance in drug‐resistant human breast carcinoma cells …

Therapeutic strategy for cancer immunotherapy in head and neck cancer

H Ishii, S Tanaka, K Masuyama - Advances in Cellular and …, 2015 - Taylor & Francis
Cancer immunotherapy is one of the new prospective treatments for head and neck
squamous cell carcinoma (HNSCC). This strategy can effectively induce anti-tumor effects …